During the past decade, Complexo Hospitalar de Niteroi conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complexo Hospitalar de Niteroi" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Complexo Hospitalar de Niteroi" are "Acute Respiratory Infection" (1 trials), "Crohn's Disease" (1 trials), "Lymphoma, Mantle-Cell" (1 trials), "Multiple Myeloma" (1 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Complexo Hospitalar de Niteroi" in a lesser frequency.

Most popular intervention types in "Complexo Hospitalar de Niteroi" are "Drug" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Teclistamab" (2 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complexo Hospitalar de Niteroi" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Complexo Hospitalar de Niteroi". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Complexo Hospitalar de Niteroi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complexo Hospitalar de Niteroi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".